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The Hippo tumor suppressor pathway regulates organ
size and tissue homoeostasis in response to diverse sig-
naling inputs. The core of the pathway consists of a short
kinase cascade: MST1 and MST2 phosphorylate and ac-
tivate LATS1 and LATS2, which in turn phosphorylate and
inactivate key transcriptional coactivators, YAP1 and TAZ
(gene WWTR1). The MOB1 adapter protein regulates both
phosphorylation reactions firstly by concurrently binding
to the upstream MST and downstream LATS kinases to
enable the trans phosphorylation reaction, and secondly
by allosterically activating the catalytic function of LATS1
and LATS2 to directly stimulate phosphorylation of YAP
and TAZ. Studies of yeast Mob1 and human MOB1 re-
vealed that the ability to recognize phosphopeptide se-
quences in their interactors, Nud1 and MST2 respectively,
was critical to their roles in regulating the Mitotic Exit
Network in yeast and the Hippo pathway in metazoans.
However, the underlying rules of phosphopeptide recog-
nition by human MOB1, the implications of binding spec-
ificity for Hippo pathway signaling, and the generality of
phosphopeptide binding function to other human MOB
family members remained elusive.
Employing proteomics, peptide arrays and biochemical
analyses, we systematically examine the phosphopep-
tide binding specificity of MOB1 and find it to be highly
complementary to the substrate phosphorylation spec-
ificity of MST1 and MST2. We demonstrate that auto-
phosphorylation of MST1 and MST2 on several threo-
nine residues provides multiple MOB1 binding sites with
varying binding affinities which in turn contribute to a
redundancy of MST1-MOB1 protein interactions in cells.
The crystal structures of MOB1A in complex with two
favored phosphopeptide sites in MST1 allow for a full
description of the MOB1A phosphopeptide-binding con-
sensus. Lastly, we show that the phosphopeptide bind-
ing properties of MOB1A are conserved in all but one of
the seven MOB family members in humans, thus provid-
ing a starting point for uncovering their elusive cellu-
lar functions. Molecular & Cellular Proteomics 16:
10.1074/mcp.M116.065490, 1098–1110, 2017.
First identified in Drosophila melanogaster, the Hippo sig-
naling pathway controls organ size through the regulation of
cell proliferation, apoptosis, and contact inhibition (1–7). The
pathway is molecularly and functionally conserved from flies
to mammals; however, in mammals, paralogous proteins with
apparent redundant functions exist for several of the pathway
members. Consistent with a tumor suppressor function, dys-
regulation of the Hippo pathway is associated with human
cancers (reviewed in 8, 9) though the core components them-
selves are infrequently mutated (10–12), possibly because of
a redundancy of function arising from the presence of paralo-
gous proteins.
The canonical mammalian Hippo pathway consists of a
short kinase cascade in which mammalian STE20-like protein
kinase 1 and 2 (MST1 and MST2 kinases)1 (gene names STK4
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and STK3; Hpo in flies) phosphorylate and activate the down-
stream kinases LATS1 and LATS2 (Warts in flies 6, 13). Acti-
vated LATS1 and LATS2 then phosphorylate the transcrip-
tional coactivator YAP1 and TAZ (gene names YAP1 and
WWTR1; Yorkie in flies), leading to their cytoplasmic seques-
tration and proteasome-mediated degradation (14). The core
kinase cascade is modulated by adaptor proteins, SAV1 (Sal-
vador, also known as WW45) and MOB1 (encoded byMOB1A
and MOB1B in human), both of which work to promote Hippo
pathway signaling.
MOB1 directly binds to LATS1 and LATS2, and additionally
to two related kinases, NDR1, (gene name STK38) and NDR2
(gene name STK38L) via a specialized MOB1-binding domain
N-terminal to the kinase domain (15; also see accompanying
manuscript by Xiong et al., 2017). This binding interaction
potentiates their kinase activity both in vitro and in vivo (16–
19). In addition to its role as a direct activator of the NDR and
LATS kinases, MOB1 itself is a substrate of MST1 and MST2,
and this phosphorylation increases the ability of MOB1 to
activate LATS1 and LATS2 (20, 21).
Key to its function as a Hippo pathway activator is the
ability of MOB1 to bind directly to MST1 and MST2 kinases.
Recent structural studies provided key insight into the under-
lying mechanism of binding. Rock et al. first demonstrated
that yeast Mob1 can bind in a phosphorylation-dependent
manner to the Mitotic Exit Network regulator Nud1 (22). Mu-
tational analysis identified a short linear phosphopeptide motif
within Nud1 as being sufficient for high-affinity interaction
(Kd  2.4 M for peptide sequence TVLNNYSpTVHQKVPS).
Optimization with peptide library arrays further demonstrated
that yeast Mob1 displayed a preference for pSer over pThr at
the P0 position. The basis for phosphopeptide recognition
and its conservation in human MOB1 was then demonstrated
by a crystal structure of human MOB1 bound to an optimized
Nud1-like phosphopeptide. The structure revealed an infra-
structure for binding phosphate moieties involving three basic
residues (K153, R154 and R157 in human MOB1, 22).
Subsequent studies by our group first demonstrated a link
between the phospho-recognition abilities of MOB1 and
mammalian Hippo pathway signaling. Couzens et al. per-
formed interaction proteomics studies revealing that MOB1
recruits MST1 and MST2 in a phosphorylation-dependent
manner (23) using the conserved phospho-recognition infra-
structure involving K153, R154, and R157 first discovered by
Rock et al. (22).
Ni et al. followed up on these findings by solving the crystal
structure of human MOB1B in complex with a phosphothreo-
nine-containing peptide sequence corresponding to residues
371 to 400 of MST2. In addition to confirming the generality of
the phospho-recognition mechanism predicted from prior
studies (22, 23), the structure revealed a bipartite binding
mode, in which the phosphorylated T378 moiety of MST2
bound the phospho-binding pocket of MOB1B, whereas a
hydrophobic motif encompassing residues 390 to 398 of
MST2 additionally engaged a remote secondary surface on
MOB1B.
Open questions of MOB1 function that remain to be ad-
dressed include first, what is the precise sequence preference
of human MOB1 for phosphosites in target interactors? The
MOB1 interacting sequences in human MST2 and in yeast
Nud1 employ pThr at the P0 position, however, these pThr
peptides are suboptimal when compared with the preferred
choice of pSer peptides demonstrated for yeast Mob1 in a
peptide library screen (22). Second, how does the phospho-
peptide-binding consensus of MOB1 compare with the sub-
strate phosphorylation consensus of the upstream MST1 and
MST2 targeting kinases? Do the similarities and differences in
consensus preferences account for the specificity of sites
generated and engaged by MOB1 in a biological setting?
Thirdly, is the phosphopeptide binding function of MOB1 a
general feature of the other six human MOB proteins?
To address these questions, we employed phosphopro-
teomics, seeking to characterize the sequence determinants
of substrate phosphorylation by MST1 and MST2. Using pep-
tide arrays, quantitative binding analyses, and structure de-
terminations, we also characterized the sequence depen-
dences required for high-affinity phosphopeptide binding to
MOB1. Our results help explain the observed redundancy in a
cellular context of several phosphorylation sites on MST1
(including the bipartite site crystallized by Ni et al., 21). Fur-
thermore, we demonstrate that all but one of the human MOB
proteins share the ability to bind a MST1 phosphopeptide,
thus providing a foundation for future investigations to eluci-
date the function of other MOB family members that have
poorly understood biological functions.
EXPERIMENTAL PROCEDURES
Recombinant Protein Expression and Purification—Human MST1
kinase domain (amino acids 2–326, corresponding to NCBI RefSeq
protein NP_006273), MST2 kinase domain (2–322, NP_006272),
MOB1B (2–216, NP_001231695), MOB1A (2–216, NP_060691)
wild-type and indicated MOB1A mutant proteins, MOB2 (2–237,
NP_001165694), MOB3A (2–217, NP_570719), MOB3B (2–216,
NP_079037), MOB3C (2–216, NP_660322), MOB4 (2–225, NP_
056202), MOB4RRR3AAA (2–225), and yeast Mob1 (79–314, NP_
012160) were expressed in E. coli BL21 (DE3) CodonPlus RIL cells as
N-terminal dual 6xhistidine (HIS) and glutathione S-transferase (GST),
Tobacco Etch Virus (TEV) cleavable, fusion proteins using a modified
pETM-30 vector. MOB wild-type and mutants were purified in batch
on glutathione-Sepharose resin (GE Healthcare, Uppsala, Sweden)
and eluted by cleavage from the affinity tags with HIS tagged TEV
protease. TEV protease was removed from the eluted protein by
subtractive immobilized-metal affinity chromatography. Cleaved pro-
tein was then concentrated and buffer exchanged by size exclusion
chromatography (SEC) using a Superdex 75 120 ml column (GE
Healthcare). For GST pull-downs and Far-Western analysis, the TEV
cleavage step was omitted.
Peptides for Biophysical and Structural Studies—MST1 phospho-
peptides encompassing pT353 and pT367 (15-mers) used for crys-
tallization and FITC labeled nonphosphorylated and phosphorylated
MST1 T353 peptides, T367 peptides, T329-T340 peptides, T380-T387
peptides and optimized Nud1-like peptides for fluorescence polariza-
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tion binding experiments were purchased from Biomatik (Cambridge,
ON). Peptide sequences used for crystallization studies are: T353,
VASTMTDGAN(p)TMIEH and T367, DDTLPSQLG(p)TMVINA. All pep-
tides used for biophysical studies are listed in supplemental Table S1.
Crystallization and Data Collection—Complexes of MOB1A with
MST1 phosphopeptides (pT353 and pT367) were obtained by mixing
at a 1:1.5 mole ratio. Crystals of the MOB1A - MST peptide com-
plexes were obtained by vapor diffusion using hanging drops with 1:1
mixtures of protein (at final concentration of 7 mg/ml) with a precip-
itant solution of 0.1 M MES pH 6.0, 0.2 M LiCl and 20% PEG 6000. For
diffraction studies, all protein crystals were flash-frozen in mother
liquors supplemented with 20–25% (v/v) ethylene glycol.
Crystals of MOB1ApT353 peptide complex and MOB1ApT367
peptide complex with the common space group P43212 (a  60.986,
b  60.986, c  138.486, alpha  90, beta  90, gamma  90)
contained one molecule per asymmetric unit. Diffraction data collec-
tion was performed at the NE-CAT beamline 24-ID-E (Advanced
Photon Source, Argonne National Laboratory, Argonne, IL).
Structure Solution and Refinement—X-ray data sets were pro-
cessed using the HKL2000 software (24). MOB1AMST1 phospho-
peptide structures were solved by molecular replacement using the
MOB1A core domain (PDB ID: 1PI1, 25) as a search model. Model
autobuilding was carried out in Buccaneer to build the N-terminal
extension of MOB1A (26). Model manual building was conducted in
COOT (27) and refined with Refmac (28). Clear unbiased density
allowed unambiguous modeling of the ordered regions of the MST1
phosphopeptides. See supplemental Table S1 for data collection and
model refinement statistics. X-ray costructures of MOB1ApT353
and MOB1ApT367 have been deposited to the Protein Data Bank
with PDB codes 5TWH and 5TWG, respectively.
Fluorescence Polarization Peptide Binding Assay—Twelve-point
fluorescence polarization binding measurements were performed in
triplicate in 384-well plate format using an Analyst HT (Artisan-Scien-
tific, Sunnyvale, CA) reader. Each 20 l measurement condition con-
tained 20 nM FITC labeled MST1 peptide or Nud1-like peptide and the
indicated concentration of MOB proteins in 25 mM HEPES pH 7.5,
150 mM NaCl, 2 mM DTT, and 1 mg/ml bovine serum albumin (BSA).
Kd values were obtained by fitting the results to a one site-specific
binding model using GraphPad Prism.
Peptide Arrays and Far-Western blots—Cellulose-bound peptide
arrays were prepared employing Fmoc solid phase peptide synthesis
using a MultiPep-RSi-Spotter (INTAVIS, Ko¨ln, Germany) according to
the SPOT synthesis method provided by the manufacturer, and pre-
viously described (29). Peptides were synthesized on amino-function-
alized cellulose membranes (Whatman™ Chromatography paper
Grade 1CHR, GE Healthcare Life Sciences #3001–878) and the pres-
ence of SPOTed peptides was confirmed by ultraviolet light (UV,  
280 nM). Peptide sequences were chosen for each of the phospho-
rylated sites within the sequence encompassing residues 327 to 487
of MST1 as reported in PhosphositePlus (31/01/2014, ref 30). In
addition, 15 amino acid-long peptides spanning the entire MST1
linker region (aa 327–487) were also synthesized in both phospho-
and nonphosphorylated versions (for every serine, threonine, or tyro-
sine position; supplemental Fig. S1). Subsequent arrays were gener-
ated by alanine scanning from the pT353 and pT367 peptide
sequences. The peptide arrays were soaked in 100% ethanol and
blocked in 5% milk in H2O for 6 h at 20 °C. One microgram of
GST-MOB1B (or GST alone) was used to probe the arrays at 20 °C
overnight. Following washes with PBS plus 0.1% Tween-20, the
arrays were blocked again in 5% milk for 1 h. The arrays were next
probed with anti-GST coupled to horseradish peroxidase for 1 h and
imaged with LumiGLO (Cell Signaling Technology, Danvers, MA) on
film.
For Far-Western blots, samples were first resolved by 10% SDS-
polyacrylamide gel electrophoresis and transferred to a nitrocellulose
membrane. Membranes were then incubated with 1 g of GST-
MOB1B and processed as described for the peptide arrays (except
that the soaking in ethanol was omitted).
Western Blots—Samples were resolved on 10% SDS-polyacryl-
amide gel electrophoresis and transferred onto a nitrocellulose mem-
brane, probed with the primary antibodies as indicated in legends,
followed by fluorescent secondary antibodies for mouse (CW800,
LICOR) or rabbit (CW680, LICOR, Lincoln, NE), and then directly
imaged on an Odyssey scanner (LI-COR). M2-FLAG antibody was
from Sigma-Aldrich (F1804), and anti-GST Horseradish Peroxidase
(HRP) was from GE Healthcare (RPN1236).
Mammalian Cell Expression—BirA*-FLAG or 3xFLAG tagged MST1
constructs were generated via Gateway cloning into pDEST5 BirA
FLAG pcDNA5 FRT TO or pDEST 5 Triple FLAG pcDNA5 FRT TO,
respectively (23). The accession number for the starting clone was
BC093768. Point mutations were generated by polymerase chain
reaction-directed mutagenesis (the position of the mutated amino
acids is indicated based on the reference sequence). All constructs
were sequence-verified. Stable cell lines were generated as Flp-In
293 (or HeLa) T-REx cell pools for the BirA*-FLAG-MST1 constructs
as described (31), and expression was induced for 24 h with tetracy-
cline (1 g/ml). 250 ng of 3xFLAG-MST1 constructs were transiently
transfected into HEK293 cells in 6-well format with jetPRIME (Polypus
transfection, Illkirch, France) as per the manufacturers’ instructions.
Okadaic acid was added at a concentration of 150 nM for 2.5 h unless
otherwise indicated, and DMSO was used as a negative control.
GST Pull-down Coupled to Western blot—To check the binding of
the MST1 proteins expressed from a mammalian system to MOB1B
by GST pull-down assays, cell expressing the indicated FLAG or
BirA*-FLAG-tagged MST1 constructs were lysed in CHAPS lysis
buffer [40 mM Hepes (pH 7.5), 120 mM NaCl, 1 mM EDTA, 0.3%
CHAPS] with 1 protease inhibitors (Sigma-Aldrich, St. Louis, MO)
after treatment with 150 nM okadaic acid for 2.5 h. Lysate was then
incubated for 2 h with  1 g GST-MOB1 immobilized onto 20 l
packed glutathione-Sepharose beads. Beads were washed 3 times
with CHAPS buffer, and SDS sample buffer was added directly to the
beads for elution and loading onto SDS-PAGE gels which were pro-
cessed for immunoblotting as described above.
Determination of the MST1 and MST2 Phosphorylation Consen-
sus—To determine phosphorylation consensus for recombinantly ex-
pressed MST1 and MST2 kinase domains, a whole-cell lysate kinase
assay was employed (32). Essentially: HeLa cells were grown to
confluency in SILAC (33) media (DMEM, 10% dialyzed FBS, 1%
penicillin/streptomycin  50 mg/L of light (K0, R0), medium (K4, R4)
or heavy (K8, R10) amino acids). Cells were pelleted in ice-cold PBS.
Frozen pellets were thawed into Nonidet P-40 buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF, 1:500 Sigma-
Aldrich protease inhibitor mixture P8340), at 500 l per plate of cells.
Two hundred fifty units of benzonase (Novagen, Billerica, MA) were
added per 2.5 ml of lysis buffer and the sample was passed through
a 25 gauge needle five times. The sample was then sonicated for 30 s
(10 s on, 2 s off) and then placed at 4 °C for 30 min with rotation. The
sample was then spun at 10,000  g for 10 min to pellet debris.
Protein concentration was determined by Bradford assay (Bio-Rad,
Mississauga, ON). 3 mg aliquots of SILAC-labeled lysate were treated
with 100 l (packed) Phos-Select IMAC resin (Sigma-Aldrich) for 1 h
at 4 °C to remove abundant and heavily phosphorylated proteins
(resin was prewashed twice with mass spectrometry-grade water).
The resin was removed by centrifugation and the supernatant col-
lected. The lysate was treated with 5-(4-fluorosulfonylbenzoyl)ad-
enosine (FSBA) at a concentration of 20 mM (in DMSO) for 1 h at 30 °C
at a protein concentration of 2 mg/ml to inhibit all endogenous ki-
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nases. Following FSBA-treatment, 3 mg lysate aliquots were diluted
with 4.35 ml of desalting buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl)
and precipitated FSBA was removed by centrifugation at 10,000  g.
Samples were then desalted and concentrated to 4 mg/ml using
Pierce 7 ml 9kDa molecular weight cutoff concentrators (catalogue:
87748). The lysate was then diluted with one volume of 2x kinase
assay buffer (40 mM MOPS, pH 7.2, 50 mM -glycerophosphate, 10
mM EGTA, 2 mM NaVO4, 2 mM DTT, 20 mMMgCl2, 20 mMMnCl2, 2 mM
ATP).
Recombinant MST1 and MST2 were then added to the inactivated
lysate at 1 g/mg of lysate to the medium and heavy SILAC samples,
respectively (swapped for replicates), and whole lysate kinase reac-
tions were performed at 30 °C for 2 h. For the reduction of cysteines,
DTT was added to 5 mM and the samples placed at 60 °C for 15 min,
then allowed to cool for 15 min at room temperature. For alkylation,
iodoacetamide was added to a final concentration of 10 mM and
the sample left for 30 min at room temperature in the dark. The SILAC
samples (L, M, H) were then pooled and CaCl2 added to 10 mM. The
sample was split in half and each half was digested with either trypsin
or chymotrypsin at a ratio of 1:60 w/w overnight at 37 °C. In the
morning, an additional 40 g of trypsin or chymotrypsin was added,
and the digestion incubated for another 3 h. The sample was acidified
to pH 2 with formic acid and desalted using 200 mg of Sep-Pak C18
(37–55 m particle size, Waters, catalog: 186004618) in a vacuum
manifold column. The desalted sample was vacuum centrifuged to
100 l and diluted with 300 l of RBD buffer (35% lactic acid, 60%
ACN, 2.5% TFA). 40 mg of TiO2 was washed thrice, sequentially with
methanol, H2O and LAS (25% lactic acid, 60% ACN, 2.5% TFA) and
then divided into two 20 mg aliquots. One aliquot was added to the
lysate and left to nutate for 15 min. Unbound supernatant was then
added to the other TiO2 aliquot suspend in DB (60% ACN, 2.5% TFA)
for 15 min. Following incubation, the TiO2 aliquots were pooled and
washed sequentially in LWS (12.5% lactic acid, 60% ACN, 2.5%
TFA), 80% ACN  0.1% TFA, 0.1% TFA and H2O. Phosphopeptides
were sequentially eluted with 200 l of 50 mM ammonium bicarbon-
ate, 5% NH4OH, 5% piperidine, 5% pyrrolidine and each eluted
fraction acidified with formic acid to pH 2.7. Finally, the samples were
desalted using 75 l of packed Poros 20 R2 resin in a microspin
column. The piperidine and pyrrolidine fractions were pooled for
analysis.
Samples were analyzed by nano-LCMS using a home-packed 0.75
m x 10 cm C18 emitter tip (Reprosil-Pur 120 C18-AQ, 3 m). A
NanoLC-Ultra HPLC system (Eksigent, Dublin, CA) was coupled to an
LTQ Orbitrap Velos (Thermo Fisher Scientific, Waltham, MA) and
samples were analyzed in data-dependent acquisition mode. High-
resolution MS scans (60,000) were followed by data dependent se-
lection of the top 15 ions for MS/MS in CID mode with 20 s exclusion
times. The LC gradient was delivered at 200 nl/m and consisted of
a ramp of 2–35% acetonitrile (0.1% formic acid) over 90 m, 35–80%
acetonitrile (0.1% formic acid) over 5 ms, 80% acetonitrile (0.1%
formic acid) for 5 m, and then 2% acetonitrile for 20 m. The raw files
and Maxquant output folder that can be used for visualization of the
results (see below) are deposited in the MassIVE repository housed
at the Center for Computational Mass Spectrometry at University
of California, San Diego (UCSD) (http://massive.ucsd.edu). This
partial MassIVE submission has been assigned the MassIVE ID
MSV000080315, ftp://massive.ucsd.edu/MSV000080315.
Mass Spectrometric Data Analysis for the MST1 and MST2 Kinase
Consensus—Raw files were searched and quantified using Maxquant
(34) version 1.2.2.5 using the Uniprot database (84887 sequences, 20
November, 2012). Cysteine residues were searched as a fixed mod-
ification of 57.0215 Da, oxidized methionine residues as a variable
modification of 15.9949 Da and deamidated asparagine and gluta-
mine residues as a variable modification of 0.9840. Medium and
heavy SILAC labeling of lysine (K) and arginine (R) residues were set
as variable modifications of 4 Da for medium R and K and 10Da
for heavy R and8Da for heavy K. Peptides were queried using either
trypsin or chymotrypsin cleavage constraints with a maximum of two
missed cleavages sites. The mass tolerances were 6 ppm for precur-
sors masses and 0.5 Da for fragment masses. The peptide false-
discovery rate was set to 0.01. Phosphopeptides with a SILAC ratio of
at least 3 relative to the control in both replicates were accepted as
target substrate peptides. The consensus phosphorylation motif was
defined using amino acids  6 residues relative to the target site.
Because 82% of sequences contained a target threonine, we used
only these sequences in generating the consensus motif. The se-
quence logo was created using pLogo (35) with a background of all
human protein sequences.
Determination of MOB4 Interactors by GST Pull-down Assays from
Cellular Lysate—HeLa cells were grown to confluency and treated
with 150 mM okadaic acid for 2.5 h. Cells were harvested in PBS and
the pellet flash-frozen. The pellet was thawed in lysis buffer (50 mM
Tris-HCl, pH 7.4, 100 mM NaCl, 10 mM MgCl2, 1% Nonidet P-40, 10%
glycerol, 1 mM PMSF, 1 mM sodium orthovanadate, 100 mM NaF and
1:500 Sigma-Aldrich protease inhibitor mixture P8340) at a 1:4 ratio
(pellet weight/volume) and resuspended by pipetting up and down.
Two hundred fifty units of benzonase (Novagen) were then added and
the sample sonicated for 30 s at amplitude 0.37 (10 s pulse, 2 s off).
Following sonication, the sample was nutated at 4 °C for 30 min and
then centrifuged at 18,000  g for 20 min at 4 °C. The supernatant
was passed through a 0.2 m filter to remove any remaining cell
debris. Twenty micrograms of packed glutathione beads were
washed twice in PBS, and incubated with either PBS or bacterial
lysate containing either GST-tagged MOB4 WT or MOB4RRR3AAA
mutant for 30 min and subsequently washed three times with PBS.
Two milligrams of centrifuged cell lysate was added to the glutathione
beads and incubated for 2 h at 4 °C with gentle agitation. The beads
were then pelleted by centrifugation at 1000  g for 1 min. The
supernatant was removed and the beads washed sequentially once
with 500 l of cold lysis buffer and twice with 500 l of cold wash
buffer (50 mM Hepes-NaOH pH 8.0, 150 mM NaCl, 2 mM EDTA, 0.1%
Nonidet P-40 and 10% glycerol). The beads were transferred to a
fresh microcentrifuge tube and washed twice with 500 l of 20 mM
Tris-HCl, pH 8. Proteins were eluted from the beads using 0.5 M
NH4OH and the eluate was vacuum-centrifuged to dryness. Dried
protein was resuspended in 100 l of 50 mM ammonium bicarbonate,
pH 8.5, containing 500 ng of trypsin and incubated at 37 °C overnight
(15 h). In the morning, another 500 ng of trypsin was added in 20 l
of ammonium bicarbonate and the sample left for another 4 h. The
digestion was terminated by the addition of 2% formic acid, the
sample was then vacuum centrifuged to dryness.
Mass Spectrometric Analysis of GST Pull-downs—Peptides were
analyzed as described above for the determination of the MST1 and
MST2 consensus, except each 60,000 resolution MS scan was fol-
lowed by 10 CID MS/MS ion trap scans. This data set consisting of 6
raw files and associated peak list and results files has been deposited
in ProteomeXchange through partner MassIVE as a complete
submission and assigned the MassIVE ID MSV000080566 and
PXD005963, ftp://massive.ucsd.edu/MSV000080566.
Mass Spectrometry Data Analysis of GST Pull-downs—Raw files
were converted to mzXML and mgf files using ProteoWizard 3.0.4468
(36) and analyzed using the iProphet pipeline (37) implemented within
ProHits (38) as follows. The database consisted of the human and
adenovirus sequences in the RefSeq protein database (version 57)
supplemented with “common contaminants” from the Max Planck
Institute (http://141.61.102.106:8080/share.cgi?ssid0f2gfuB) and
the Global Proteome Machine (GPM; http://www.thegpm.org/crap/
index.html). The search database consisted of forward and reverse
Phospho-recognition by MOB1
Molecular & Cellular Proteomics 16.6 1101
sequences (labeled “gi 9999” or “DECOY”); in total, 72,226 entries
were searched. Spectra were analyzed separately using Mascot
(2.3.02; Matrix Science) and Comet [2012.01 rev.3 (39)] with trypsin
specificity and up to two missed cleavages; deamidation (Asn or Gln)
and oxidation (Met) were selected as variable modifications. The
mass tolerance of the precursor ion was set at 12 parts per million
(ppm), the fragment ion tolerance at  0.6 amu. The resulting Comet
and Mascot results were individually processed by PeptideProphet
(40) and combined into a final iProphet output using the Trans-
Proteomic Pipeline (TPP; Linux version, v0.0 Development trunk rev 0,
Build 201303061711). TPP options were as follows: general options
were -p0.05 -x20 -d“gi 9999,” iProphet options were -ipPRIME, and
PeptideProphet options were -OpdP. All proteins with a minimal
iProphet probability of 0.05 were parsed to the relational module of
ProHits. For analysis with SAINT, only proteins with an iProphet
protein probability of 0.95 were considered. Hits were also re-
stricted to those detected with a minimum of two unique peptides.
Interaction Scoring for the GST Pull-downs—Pull-downs were per-
formed in duplicates and analyzed with SAINTexpress (41). Proteins
with FDR of 1% and at least two unique peptides were considered
true positive interactions. Visualization of the interactions as dot plots
was through prohits-viz.lunenfeld.ca, which was first introduced in
(42); once a particular prey passes the selected FDR threshold for at
least one bait, all the quantitative data across all baits are retrieved
and displayed. On these dot plots, the color intensity maps to the
averaged spectral counts across both replicates (capped at the indi-
cated maximal value), whereas the size of the circles indicates the
relative abundance of a prey with regards to its maximum value. The
confidence score (FDR) from SAINTexpress is mapped as the edge
color.
Experimental Design and Statistical Rationale—For the GST pull-
down data, biological duplicates were employed, and statistical scor-
ing against two negative controls was performed using Significance
Analysis of INTeractome (SAINT) as described in “Interaction Scoring
for AP-MS”. Average SAINT score was used to determine the Bayes-
ian FDR, which therefore requires a high confidence interaction
across both biological replicates. For the consensus phosphorylation
motif screen, technical replicates were performed for the control,
MST1 and MST2 labeling experiments, permutating the SILAC labels
between replicates as described above.
RESULTS
MOB1 Phosphorylation-dependent Interaction with MST1
is Direct and Maps to Regions C-terminal to the Kinase Do-
main—We previously demonstrated that MOB1 interacted in a
phosphorylation-dependent manner with MST1, and that its
association with MST1 and MST2 was abrogated by mutation
of the MOB1B phosphate coordinating residues K153, R154
and R157. This suggested an underlying binding mode be-
tween MOB1 and MST1 like that revealed for MOB1 binding
to a Nud1 derived phosphopeptide (22). However, inspection
of the amino acid sequence of MST1 did not reveal obvious
homology to the Nud1 derived phosphopeptide sequence
(supplemental Fig. S1A). Because we surmised that the phos-
pho-dependent binding of MST1 and MST2 to MOB1 could
have functional consequences on Hippo pathway signaling
and regulation, we set out to investigate the determinants for
the MST1-MOB1 interaction in greater detail.
MST1 is comprised of two structured domains: a protein
kinase domain located at its amino terminus (aa 26–327; Fig.
1A) and a SARAH domain that mediates homo and hetero-
dimerization at its carboxyl terminus (aa 430–480, ref 43). An
unstructured linker region that harbors multiple phosphoryla-
FIG. 1. Phospho-dependent interaction of MST1 kinase with MOB1. A, MST1 kinase domain architecture, highlighting multiple phos-
phothreonine sites available for phospho-dependent interaction with MOB1. Constructs used for studies in panel B are highlighted. B, HeLa
stable cell lines expressing full-length BirA*-FLAG-MST1, MST1 aa 1–327, and MST1 aa 328–487 were subjected to a GST-MOB1B pull down
(top panel). Expression level controls for BirA*-FLAG-MST1 constructs are shown in the bottom panel. C, Far-Western analysis to study
phosphorylation-dependent interactions with GST-MOB1B. HeLa cells stably expressing BirA*-FLAG-MST1 aa 328–487 at were treated with
okadaic acid or vehicle (DMSO). BirA*-FLAG-MST1 was affinity purified, separated by SDS-PAGE, transferred to a nitrocellulose membrane
and incubated with GST-MOB1B or with GST alone as a control. Signal was detected using anti-GST coupled to Horseradish Peroxidase and
imaged with LumiGLO substrate on film. Control detection of immunoprecipitated FLAG-MST1 was performed by anti-FLAG Western blot.
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tion sites (aa 328–429, ref 30, 44) separates the two struc-
tured domains. To identify the portion of MST1 necessary for
recruitment to MOB1A, we stably expressed BirA*-FLAG-
tagged full-length MST1, the kinase domain only (aa 1–327),
and a C-terminal fragment containing both the linker and the
SARAH domain (aa 328–487) in HeLa cells. Cells were treated
with the protein phosphatase inhibitor okadaic acid to maxi-
mize the accumulation of phosphorylated proteins (23). Ly-
sates were generated and subjected to pull-downs using
recombinant bacterially-expressed GST-MOB1B immobilized
on glutathione Sepharose resin. The recovery of MST1 was
then monitored by immunoblotting using an anti-FLAG anti-
body (Fig. 1B). Full-length MST1 and the C-terminal fragment,
but not the kinase domain alone, were recovered in the pull-
down. We concluded that the MOB1B-binding region local-
ized to the C-terminal portion of MST1.
To confirm that the interaction was phosphorylation-de-
pendent, and to assess whether it was direct, we employed a
Far-Western assay (45). We treated stable HeLa cells ex-
pressing BirA*-FLAG-MST1 C terminus (aa 328–487) with
either DMSO (vehicle control) or okadaic acid. MST1 was
recovered by anti-FLAG immunoprecipitation (to enrich for the
expressed proteins and to improve assay sensitivity) and sep-
arated by SDS-PAGE. Proteins were transferred onto nitro-
cellulose, and Far-Western analysis was performed using
GST alone or GST-MOB1B as probes (Fig. 1C; immunoblot-
ting with anti-FLAG antibody was used to monitor relative
expression levels and immunopurification efficiency, bottom
blot). Although no binding signal was detected when GST-
alone was used as probe, a band corresponding to MST1 was
clearly visible in the FLAG-MST1 immunoprecipitates probed
with GST-MOB1B. In addition, the intensity of the binding
signal was increased severalfold in the okadaic acid-treated
sample, confirming the expected phospho-dependence.
These results demonstrated that the association between
MST1 and MOB1 was direct and that the phosphorylation-
dependent elements resided within MST1 itself (aa 328–487).
Phosphorylated T353 and T367 Containing 15-mer Pep-
tides Within the Interdomain Linker of MST1 are Sufficient for
Direct Binding to MOB1—We next repurposed the Far-West-
ern assay with GST-MOB1B to identify the specific binding
sites within the C terminus of MST1 using a peptide array
strategy. We synthesized 15 amino acid-long peptides with
the MST1 phosphorylation sites reported in PhosphositePlus
between aa 328–487 (30), including both phosphorylated and
nonphosphorylated versions of each. We further synthesized
nonoverlapping 15-mers spanning the entire MST1 C-terminal
region (aa 328–487) with combinatorial multisite phosphoryl-
ation when applicable. The phosphorylated and nonphospho-
rylated peptides derived from Nud1 (22) were used as positive
and negative MOB1B binding controls, respectively. Peptide
overlay analysis (here referred to as Far-Western) revealed
that peptides bearing phosphorylated forms of T353 and T367
consistently gave the highest binding signals across the array;
nonphosphorylated versions of these peptides generated little
to no binding signal (supplemental Fig. S1B, S1C). Several
phosphopeptides yielded intermediate binding signals, as did
unexpectedly two nonphosphorylated peptides (supplemen-
tal Fig. S1C; discussed below).
To confirm that nonimmobilized peptides bearing phospho-
rylated T353 and T367 could bind MOB1A in solution, we
conducted fluorescence polarization experiments using
recombinantly-expressed wild-type MOB1A and fluores-
cently-labeled MST1 peptides. MST1 T353 and T367 pep-
tides displayed high phospho-dependent binding affinities
for MOB1A, with Kds of 280 nM and 680 nM for the phospho-
rylated peptides, respectively, and no detectable binding for the
nonphosphorylated peptides (Fig. 2A). Consistent with our pre-
vious results indicating that coordination of the phosphate
group by three basic amino acids in MOB1 (first identified in ref
22) was responsible for phosphorylation-induced interaction
with MST1 (23), a recombinant MOB1A mutant bearing alanine
substitutions at positions K153, R154, and R157 displayed no
measurable binding to either of the phosphorylated peptides
(Fig. 2B).
Like MST1, MST2 was also recruited to MOB1 in a phos-
phorylation-dependent manner (23), suggesting that the se-
quence elements that mediate MOB1 recruitment are con-
served between MST1 and MST2. MST1 and MST2 share
59% identity in their C-terminal segments, and both T353 and
T367 sites are conserved (Fig. 2C). We next validated that the
paralogous sequences derived from MST2 also associated
with MOB1B in a phosphorylation-dependent manner (Fig.
2D). We further noticed that the T353 and T367 sites are
conserved in Hpo, the Drosophila MST1 and MST2 ortholog,
though the sequence surrounding the site orthologous to
T353 was somewhat divergent (Fig. 2C). Fly peptides ortholo-
gous to T353 and T367 also bound to human MOB1B in our
Far-Western overlay assay in a phosphorylation-dependent
manner (Fig. 2D; note that these binding experiments were
performed with human MOB1B as we could not readily express
the recombinant Drosophila MOB1 protein Mats in bacteria).
These results suggested that the two conserved phosphoryla-
tion sites in MST1 are capable of mediating phosphorylation-
dependent interactions with MOB1 across species.
The Phosphorylation Consensus of MST1 is a Close Match
to the Phosphopeptide-binding Consensus of MOB1—We
sought to explore the specificity determinants for phospho-
dependent binding of MOB1B using peptide arrays and Far-
Western detection, by substituting each residue individually in
the human pT353 and pT367 peptide sequences. Our initial
analysis revealed a strong preference for phosphothreonine
over phosphoserine, and near complete loss of binding for
phosphotyrosine at the P0 peptide position (Fig. 3A). Alanine
substitutions across the pT353 and pT367 peptide sequences
identified further strong binding determinants C-terminal to
the phosphorylation site, whereas positions N-terminal to the
phosphorylation site appeared permissive to alanine (Fig. 3B).
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To define a consensus for the preferred binding motif, we
substituted positions 	2 to 2 of the pT353 peptide (supple-
mental Fig. S2) and positions 1 to 4 of the pT367 peptide
(supplemental Fig. S3) with all possible naturally occurring
amino acids. A summary of the binding consensus derived
from the Far-Western analysis is shown in sequence logo
form in Fig. 3C. Most notably, in addition to the strong pref-
erence for phosphothreonine at the P0 position, a strong
preference for hydrophobic residues at positions 1 to 3
was also observed. Beyond these core positions, little dis-
crimination of sequence was detected.
As predicted based on the consensus derived from our
peptide arrays, free fluorescently-labeled peptides corre-
sponding to four other phosphothreonine-containing se-
quences in the linker region of MST1 (T329, T340, T380, and
T387) bound much more weakly to recombinant MOB1A (Fig.
3D, Fig. 2A, supplemental Fig. S4A, S4B). The weaker binding
affinities for these phosphopeptides relative to the high affinity
pT353 and pT367 peptides could be rationalized by mis-
matches to one or more positions in the consensus (Fig. 3C,
3D). Consistent with their P0 positional binding preferences,
human MOB1 bound more tightly to the MST1 pT367 peptide
than to the optimized Nud1-like phosphoserine containing
peptide than did yeast Mob1, and vice versa (Supplemental
Fig. S4C, S4D,).
Interestingly, the MST1 peptide sequences that interacted
most tightly with MOB1B in our peptide arrays bore sequence
similarity to the phosphorylation consensus we determined
for the MST1 and MST2 kinases using a whole cell lysate
system (Fig. 3E); see Experimental Procedures and (32).
Briefly, to determine the phosphorylation consensus se-
quence, HeLa cell were grown in SILAC (Stable isotope label-
ing using amino acids in cell culture) media (light, medium,
heavy, see ref 33). Cell lysates were prepared with endoge-
nous kinases inactivated using 5-(4-fluorosulfonylbenzoyl)
adenosine (FSBA), followed by buffer exchange to remove
residual FSBA. Recombinantly-expressed MST1 and MST2
kinase domains were incubated with medium and heavy SI-
LAC lysates, whereas the light SILAC lysate was used for the
negative (no kinase added) control (see Experimental Proce-
dures for details and information on label swaps). Samples
were pooled, proteolyzed and phosphopeptides were en-
riched using titanium dioxide. Phospho-enriched samples
were analyzed by quantitative mass spectrometry and phos-
FIG. 2. Phosphopeptides from MST1 interdomain linker region directly interact with MOB1A in vitro. A–B, Fluorescence Polarization
measurement of the binding of MOB1A to phosphorylated and nonphosphorylated variants of MST1 T353 and T367 peptides (left). Fluorescent
polarization measurement of binding between MOB1A WT or a KRR33A mutant and the indicated MST1 phosphopeptides (right). Data is
plotted as the mean S.E. (n 3); N.D. indicates that the Kd could not be determined. C, Sequence alignment of the inter domain linker region
of MST1 and MST2 from humans to flies. The most conserved Thr residues are highlighted in red and less conserved Thr residues are
highlighted in pink. H.s., Homo sapiens, M.m., Mus musculus; B.t., Bos taurus; G.g., Gallus gallus; X.l., Xenopus laevis; D.r., Danio rerio; D.m.,
Drosophila melanogaster. D, Peptide array studies to define MOB1B phospho-dependent interaction sites in human MST2 and Drosophila Hpo
proteins that are orthologous to the human MST1 T353 and T367 sites.
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phopeptides that were enriched in either the MST1 or MST2
samples (in comparison to the no kinase samples) were iden-
tified. Our analysis identified 619 MST1 and MST2 target
phosphorylation sites (supplemental Table S2). Enriched se-
quences showed a strong preference for phosphothreonine
over phosphoserine at the P0 position. In addition, within the
phosphothreonine-containing peptides a preference for hy-
drophobic residues in the p  1 position was observed, like
the MOB1 phosphopeptide-binding consensus. Only a small
degree of mismatch was observed between the MOB1B bind-
ing consensus and MST1 and MST2 kinase consensus at the
p  2 position, where lysine was preferred by the kinase but
not selected for by MOB1B (Fig. 3E). Based on these results,
we predicted that MST1 has a strong intrinsic ability to auto-
phosphorylate at the T353 and T367 positions, which would
create ideal binding sites for MOB1.
Structural Basis for High Affinity Binding of MOB1A to Op-
timal MST1 Phosphopeptides—To determine the structural
basis for the binding specificity of MOB1A for preferred phos-
phopeptide sequences, we solved the X-ray crystal structures
of full-length nonphosphorylated human MOB1A bound to
human MST1 pT353 and pT367 phosphopeptides at 2.5Å and
2.1Å resolution, respectively (Fig. 4A, 4B, supplemental Fig.
S6A; see also supplemental Fig. S5 for a structure based
sequence alignment and supplemental Table S3 for data col-
lection and model refinement statistics). The observed bind-
FIG. 3. MST1 and MST2 kinases may self-potentiate phospho-dependent binding to full-length MOB1. A, Far-Western peptide array
assays to define preferences for the phosphorylated amino acid at the P0 position of a MST1 T353 peptide. B, Positional alanine scanning of
MST1 pT353 and pT367 peptides to define positions important for GST-MOB1B binding by Far-Western peptide array. C, Sequence logo
representation of the phosphopeptide binding consensus of MOB1B determined by MST1 peptide arrays (See supplemental Fig. S2 and S3).
D, Amino acid sequence and binding affinity of MST1 phosphopeptides for MOB1A (see Fig. 2A and supplemental Fig. S4A and S4B). E,
Sequence logo representation of the substrate phosphorylation consensus for recombinant MST1 and MST2 determined from a whole-cell
lysate kinase assay by SILAC labeling and quantitative phosphoproteomics (See supplemental Table S2).
FIG. 4. Crystal structure of full-length MOB1A bound to a MST1
pT367 phosphopeptide. A, Overview of the crystal structure of an
MST1 pT367 peptide (light blue) bound to MOB1A (green). B, Detailed
surface view of the contact region between an MST1 pT367 peptide
and MOB1A. The MST1 pT367 peptide is shown in stick representa-
tion and MOB1A is shown in a transparent surface representation.
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ing modes revealed by these structures are in close agree-
ment with the binding modes reported previously for a yeast
Nud1 derived phosphopeptide in complex with human
MOB1A, as well as a MST2 T378 phosphopeptide in complex
with human MOB1B (supplemental Fig. S6B, S6C; see ref 21,
22). However, we note that the phosphopeptides crystallized
in those earlier studies deviated to some extent from the
preferred MOB1B phospho-binding consensus presented
here (Fig. 3C and supplemental Fig. S6B, S6C).
As predicted by prior mutational data, the MST1 pT353 and
pT367 phosphopeptides bound to the MOB1A phospho-
binding pocket first identified by Rock et al. (22), with the
phosphate of the P0 threonine directly coordinated by K153,
R154 and R157. The strong preference for Thr over Tyr can be
rationalized by the limited size of the phospho-binding pocket
that cannot accommodate the bulky Tyr side chain. The pref-
erence for Thr over Ser was less obvious because the -
methyl orients out to solvent. However, we hypothesize that
the more constrained rotational mobility of the Thr versus Ser
side chain would help to orient the attached phosphate group
for optimal interactions with MOB1A (46).
The p  1 side chains of M354 and M368 on MST1-pT353
and MST1-pT367 peptides respectively resided in an expan-
sive hydrophobic surface composed by A89, A92, Y93, Y95,
F156 and A160 side chains on MOB1A. The p  3 side chain
of I370 in the MST1-pT367 peptide oriented toward the same
hydrophobic surface. The p  2 side chains of I355 and V369
in MST1-pT353 and MST1-pT367 peptides respectively
pointed to a distinct surface composed by M87, Y95 and the
aliphatic portion of the E94 side chain on MOB1A. Thus, the
hydrophobic nature of the p  1 to p  3 binding surfaces
explained the consensus preferences for hydrophobic resi-
dues at these positions. The main chain regions beyond P-1
and p  4 oriented toward solvent, which explained the lack
of specificity beyond these positions.
Ni et al. recently reported the crystal structure of MOB1
bound to an extended phosphopeptide derived from MST2
encompassing T378 (supplemental Fig. S6C, ref 21). This
considerably longer peptide sequence (31 residues versus the
15-residue peptides described here) appeared suboptimal in
having disfavored basic residues at positions p  2 and p 
3, and yet was reported to bind more tightly (120 nM) to
MOB1B (21) than did the consensus matching shorter MST1
pT353 peptide. We reason that the suboptimal match to the
consensus was compensated for by the observed secondary
contacts involving residues far C-terminal to the phosphosite
in MST2 (corresponding to an -helical stretch of residues
391 to 397), which engaged a surface on MOB1B remote from
the MOB1B phosphopeptide binding pocket. In support of
this hypothesis, we observed that the orthologous peptide
region in MST1 (residues 391 to 405, containing the nonphos-
phorylated PSFLEYF sequence) was sufficient to bind to
MOB1B in our peptide array assays (supplemental Fig. S1C).
With the exception of MOB2, all human MOB proteins
display some conservation of the basic residues at positions
corresponding to K153, R154 and R157 in MOB1A, suggest-
ing that they too may possess an ability to bind phosphopep-
tide sequences (supplemental Fig. S5). In support of this
hypothesis, we found that all human MOB proteins with the
exception of MOB2 displayed quantifiable affinity for the
MST1 pT367 peptide in fluorescence polarization assays, with
Kds ranging from 2–3 M for the three MOB3 proteins to 12.2
M for MOB4 (Fig. 5A). To validate whether this binding was
dependent of the projected phosphopeptide binding infra-
structure of each MOB protein and whether it could occur in
the competitive environment of a cellular lysate, we performed
GST pull-down experiments with the most divergent member of
the family, MOB4, which showed only modest (12.2 M) phos-
phopeptide binding function in vitro. To this end, recombinantly
expressed GST-MOB4 wild-type protein as well as a GST-
MOB4 mutant in which the predicted phosphate coordinating
residues R161, R162, and R165 were mutated to alanine, were
employed in GST pull-down analyses using cellular lysates
treated with okadaic acid. Analysis by mass spectrometry
(against negative controls consisting of okadaic acid-treated
lysate incubated with glutathione resin alone), recovered only a
few high confidence interactors for GST-MOB4 that strikingly
included both MST1 andMST2. The association with MST1 and
MST2 (together with additional interactors) was dependent on
the predicted phosphate coordinating residues R161, R162,
and R165 (Fig. 5B). These results confirm that most human
MOB proteins have the potential to associate with phosphoryl-
ated MST1 and 2, and that they would do so by using the same
infrastructure first uncovered by Rock et al. (22).
Validation of Binding Determinants Between MST1 and
MOB1 in Cells—Next, we sought to confirm the existence of
multiple phosphorylation sites on MST1 that can independ-
ently engage with MOB1 using a cell-based system. Mutation
of the two favored in vitro sites identified here, T353 or T367,
to alanine in isolation or combined were insufficient to abro-
gate interaction with GST-MOB1B in a Far-Western assay
(Fig. 6A). Similarly, a single point mutation substituting T380
(paralogous to the previously reported T378 in MST2) to ala-
nine did not abolish MOB1B binding either (Fig. 6A). Given
that all three phosphopeptides can each independently asso-
ciate with MOB1 in vitro, we next constructed FLAG-tagged
double and triple mutants at these sites in MST1, transfected
each in HEK293 cells, stimulated the cells with okadaic acid to
maximize phosphorylation-dependent binding, and prepared
cell lysates. We next performed a GST pull-down analysis
using GST-MOB1B with each lysate and detected interac-
tions with MST1 by anti-FLAG immunoblotting. Although the
wild-type MST1 protein readily interacted with GST-MOB1B
in this assay, the MST1 mutant in which all three identified
binding sites (T353, T367, and T380) were mutated to alanine
displayed a marked reduction in association with MOB1B,
despite the fact that it was expressed at a comparable level to
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the wild-type protein (Fig. 6B; we note that the double MST1
mutant at T353 and T367 and a triple mutant at T353, T367, and
T387 also displayed a decrease in binding in comparison to
wild-type MST1, though not as strikingly as the T353, T367,
T380 triple mutant, especially when considering relative levels of
expression). Together, these mutational studies suggest that, in
a cellular context, a redundancy of sites mediate the association
of MOB1 with phosphorylated MST1, and that even phospho-
rylation sites in a suboptimal context (such as the T380 site) can
contribute to phosphorylation-dependent binding if they act in
concert with secondary peptide sequences that engage an
independent peptide recognition surface on MOB1 (Fig. 6B).
DISCUSSION
In this study, we investigated the mechanisms behind the
recruitment of MST1 and MST2 kinases to MOB1, which
facilitate signal transmission in the Hippo pathway by bringing
the MST1 and MST2 kinases in close vicinity to their sub-
strates, the LATS family kinases. Activation of MST1 and
MST2 kinases by upstream signals would facilitate autophos-
phorylation, including on sites in their linker regions (as first
reported in ref 44). Here, we show that the substrate phos-
phorylation consensus for MST1 and MST2 kinases is com-
patible with the MOB1 phosphopeptide binding consensus,
suggesting that auto-phosphorylation of MST1 and MST2
would create docking sites that are efficiently recognized by
the phosphopeptide binding infrastructure of MOB1.
The cocrystal structures of MOB1A and MST1 pT353 and
pT367 phosphopeptides reported here are in full agreement
with the binding mode first reported by Rock et al. (22), and
subsequently reported by Ni et al. (21), in which the basic
residues, K153, R154, and R157 coordinate the phosphoryl-
FIG. 5. Phospho-recognition by human MOB family proteins. A, Fluorescence polarization analysis of human MOB proteins binding to a
MST1 pT367 phosphopeptide (Top); Summary table of the calculated binding affinities exhibited by human MOB proteins to a MST1 pT367
phosphopeptide, along with overall sequence identity to MOB1A and the projected phosphate coordinating residues (Bottom). Data is plotted
as the mean  S.E. (n  3). B, Protein interactors of GST-MOB4 and GST-MOB4RRR3AAA from HeLa cell lysate treated with okadaic acid. The
circle color maps to the averaged spectral counts detected for the prey (rows) in the purification of the baits (columns); the relative abundance
across the baits for the same prey is depicted by the node size whereas the color edge maps to the confidence in identification from
SAINTexpress, expressed as FDR (visualization at ProHits-viz.lunenfeld.ca). All interactions are listed in supplemental Table S4. Also see
ProHits-web.lunenfeld.ca (project: “phospho-dependent Hippo interactions”).
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ated residue. Furthermore, our peptide array experiments not
only identified multiple peptide sites on MST1 that can inter-
act with MOB1B in a phosphorylation-dependent manner,
they also revealed a hydrophobic stretch of residues that can
interact with MOB1B in a phosphorylation independent manner.
In corroboration of the findings of Ni et al. (21), these peptides
coincide with the nonphosphorylated sequence element that
contributes to a bipartite phosphopeptide binding mechanism.
The binding features of MOB1 described above create mul-
tifold redundancy to the phosphorylation-dependent binding
of MOB1 to MST1 in cells, whereby even weaker phospho-
peptide binding sites can contribute. This behavior raises an
important question of purpose. One possibility is that the
redundancy of phosphosites in MST1 (and MST2) provides a
safeguard to the mutation of a single essential site, which
would be more likely to short circuit Hippo pathway function
and hence disable the brake on YAP1 and TEAD oncogenic
functions. A second possibility is that multiple phosphoryla-
tion sites in MST1 and MST2 allow multiple MOB1 proteins to
bind each MST1 (or MST2) kinase concurrently (similar to the
phenomenon in polyribosomes (47)), which could serve an
amplifying role in potentiating Hippo pathway signaling to the
downstream LATS1 and LATS2 kinases. A third possibility is
that the presence of multiple sites, each with varied binding
potential to MOB1, affords the cell an opportunity to fine tune
the intensity of signaling through the Hippo pathway. The newly
elucidated rules that govern the strength of phosphopeptide
recognition by MOB1 empower future studies to address these
questions of function in a rational and systematic manner.
Lastly, our studies support the notion that the phosphopep-
tide binding function of MOB1 is broadly relevant to the func-
tion of other MOB proteins. We showed that, of the seven
human MOB proteins, all but one display conservation of
basic residues at the projected phospho-coordinating posi-
tions and that this correlates with a measurable ability to bind
pThr peptides in vitro. In addition, our studies show that
MOB4 can interact with MST1 and MST2 in a manner de-
pendent on its predicted phospho-coordinating infrastruc-
ture. This not only suggests that the other more similar MOB
proteins will engage phosphopeptides in a physiological set-
ting, but that they may play hitherto unanticipated roles in
Hippo pathway signaling. Further characterization of the
phosphopeptide binding ability and specificity of each MOB
family member may assist in understanding the specific sig-
naling functions that each carry out in a cellular context.
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FIG. 6. Multiplicity of phosphosites in the MST1 interdomain
linker region provides redundancy in binding to MOB1. A, FLAG-
tagged MST1 mutants expressed in HEK293 cells treated with oka-
daic acid were subjected to Far-Western analysis. Top panel: Far-
Western blot using GST-MOB1B as a probe; bottom panel: anti-FLAG
Western blot to verify equal loading of MST1 across mutants. B, GST
pull down analysis of MOB1B interaction with MST1. WT and the
indicated mutant versions of FLAG-MST1 were expressed in HEK293
cells treated with okadaic acid, and subjected to GST pull-down
analysis with GST-MOB1B. An anti-FLAG Western blot was used to
determine the recovery of FLAG-MST1 proteins in the GST-MOB1B
pull-down and in the lysate (input). Loading of the GST-MOB1B
protein was assessed by Coomassie staining of the SDS-PAGE gel.
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